The Kidney Foundation of Canada

Dr. Dayna Lee-Baggley 

Dr. Dayna Lee-Baggley

Nova Scotia Health Authority, Nova Scotia
Co-Investigator(s):  Michael Vallis, Karthik Tennankore

Predicting and reducing non-adherence in kidney disease: Validating a novel clinical tool


2017-2019:  $100,000  |  Allied Health Research Grants  |  Category: Dialysis

Biography

Dr. Dayna Lee-Baggley is a Registered Clinical Psychologist. She obtained her Masters and Ph.D. in Clinical Psychology with an emphasis in health psychology from the University of British Columbia. She is a Clinical Health Psychologist at the Nova Scotia Health Authority (NSHA) for the Multi Organ Transplant Program, which provides liver, kidney, and pancreas transplants to Atlantic Canadians. She is also a Core Faculty of the Behaviour Change Institute (NSHA). She holds an Assistant Professor appointment in the Department of Family Medicine at Dalhousie University and an Adjunct Professor appointment in the Department of Industrial and Organizational Psychology at Saint Mary’s University. She is the president of the Atlantic Chapter of the Association for Contextual Behavioral Science and the vice-chair of the Halifax Chapter of the Canadian Obesity Network. Her areas of expertise include self-management of chronic disease, facilitating health behavior change, managing and treating obesity, and professional resiliency for healthcare providers. She provides training to healthcare providers in behaviour change skills for chronic disease management. She has an active research program on behavior change, chronic disease self-management, obesity, and Acceptance and Commitment Therapy. In the last 5 years she has presented over 45 workshops and presentations to more than 2,500 healthcare providers, researchers, and members of the general public.  Dr. Lee-Baggley has been funded by local, provincial, and national research granting agencies. She has over 35 peer-reviewed publications and over 110 scholarly presentations.

Lay Summary

Regularly attending prescribed dialysis is a key health behaviour that can improve the health of individuals living with kidney disease. Attending dialysis is both a life saving and a difficult health behaviour for individuals with kidney disease. The proposed study aims to improve the lives of people affected by kidney disease by studying an innovative clinical tool which may help improve attendance (i.e., reduce “no-shows”) for dialysis treatment.

No-shows or non-adherence can be understood by assessing a patient’s readiness to engage in the recommended health behaviour. However, current means of assessing readiness are cumbersome or too long to use in a clinical context. In the proposed study we present a novel means of assessing the likelihood of no- shows called the Traffic Light Assessment. The Traffic Light Assessment is a 4-question interview that allows a healthcare provider to capture whether a patient is ready (i.e., green light), on the fence (i.e., yellow light), or not ready (i.e., red light) to attend dialysis.

In order to test if the Traffic Light Assessment can predict whether a patient will attend dialysis, each participant will participate in a Traffic Light Assessment with a trained research assistant the day before their prescribed dialysis treatment for the upcoming week. Their attendance at dialysis will be tracked through their hospital charts. The research assistant will also contact the participant at the end of the week to learn more about anything that may have affected their attendance during the week and the impact of the Traffic Light Assessment on the participant’s behaviour. In order to test the longer term impact of the Traffic Light Assessment, we will examine attendance rates for the participant for 3 months prior to the Traffic Light Assessment and for 3 month and 6 months after the Traffic Light Assessment. These rates will be compared to rates for patients who have not yet received the Traffic Light Assessment.

Consistent with the mission of the Kidney Foundation of Canada to promote education and access to high quality healthcare, the results of this study will be shared with healthcare providers and will help to improve attendance for dialysis, thereby reducing wasted time due to no-shows or expensive emergency services and improving access for those who need dialysis. In testing an innovative clinical tool designed to predict and reduce no-shows for dialysis, this project has a high potential to directly impact the health and well- being of individuals living with kidney disease.